[go: up one dir, main page]

DK2624865T3 - Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies - Google Patents

Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies Download PDF

Info

Publication number
DK2624865T3
DK2624865T3 DK11770625.9T DK11770625T DK2624865T3 DK 2624865 T3 DK2624865 T3 DK 2624865T3 DK 11770625 T DK11770625 T DK 11770625T DK 2624865 T3 DK2624865 T3 DK 2624865T3
Authority
DK
Denmark
Prior art keywords
antibody
ser
concentration
pharmaceutical formulation
leu
Prior art date
Application number
DK11770625.9T
Other languages
Danish (da)
English (en)
Inventor
Daniel B Dix
Xiaolin Tang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2011/054856 external-priority patent/WO2012047954A1/en
Application granted granted Critical
Publication of DK2624865T3 publication Critical patent/DK2624865T3/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK11770625.9T 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies DK2624865T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39028310P 2010-10-06 2010-10-06
PCT/US2011/054856 WO2012047954A1 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (il-4r) antibodies

Publications (1)

Publication Number Publication Date
DK2624865T3 true DK2624865T3 (en) 2018-10-22

Family

ID=45995014

Family Applications (2)

Application Number Title Priority Date Filing Date
DK11770625.9T DK2624865T3 (en) 2010-10-06 2011-10-05 Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
DK18161288.8T DK3354280T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK18161288.8T DK3354280T3 (da) 2010-10-06 2011-10-05 Stabiliserede formuleringer indeholdende anti-interleukin-4-receptor- (IL-4R) antistoffer

Country Status (14)

Country Link
AR (1) AR083338A1 (pt)
DK (2) DK2624865T3 (pt)
ES (2) ES2820246T3 (pt)
HK (1) HK1258305A1 (pt)
HR (1) HRP20181822T1 (pt)
HU (1) HUE052089T2 (pt)
LT (1) LT2624865T (pt)
PT (1) PT3354280T (pt)
RS (1) RS57850B1 (pt)
SI (1) SI2624865T1 (pt)
SM (1) SMT201800488T1 (pt)
TW (7) TWI498121B (pt)
UA (1) UA111731C2 (pt)
UY (1) UY33652A (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015003590A8 (pt) 2012-08-21 2017-10-31 Sanofi Sa Métodos para tratamento ou prevenção da asma por administração de um antagonista de il-4r
HUE046410T2 (hu) * 2013-06-21 2020-03-30 Sanofi Biotechnology Eljárások orrpolipózis kezelésére IL-4R-antagonista beadásával
AU2014284235B2 (en) * 2013-06-21 2019-11-21 Regeneron Pharmaceuticals, Inc. Methods for treating nasal polyposis by administering an IL-4R antagonist
WO2016077675A1 (en) 2014-11-14 2016-05-19 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
PL3703818T3 (pl) 2017-10-30 2024-03-25 Sanofi Biotechnology Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608693B2 (en) * 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
ES2332082B1 (es) * 2008-07-24 2010-10-26 Consejo Superior De Investigaciones Cientificas (Csic) 45% Sistema de alineacion de patrones en un sustrato mediante litografia por estencil.
KR101593726B1 (ko) * 2008-09-10 2016-02-18 니혼 엑스란 고교 (주) 가교 아크릴레이트계 섬유 및 이의 제조방법
CA2754528A1 (en) * 2009-03-06 2010-09-10 Genetech, Inc. Antibody formulation

Also Published As

Publication number Publication date
HK1258305A1 (zh) 2019-11-08
TW201716086A (zh) 2017-05-16
TW202320851A (zh) 2023-06-01
PT3354280T (pt) 2020-09-01
HUE052089T2 (hu) 2021-04-28
DK3354280T3 (da) 2020-09-28
SMT201800488T1 (it) 2018-11-09
TW202026011A (zh) 2020-07-16
TWI690329B (zh) 2020-04-11
TW202102262A (zh) 2021-01-16
UY33652A (es) 2012-04-30
TWI856388B (zh) 2024-09-21
TW201221141A (en) 2012-06-01
RS57850B1 (sr) 2018-12-31
ES2687813T3 (es) 2018-10-29
HRP20181822T1 (hr) 2018-12-28
ES2820246T3 (es) 2021-04-20
TWI718890B (zh) 2021-02-11
TW201542229A (zh) 2015-11-16
TWI498121B (zh) 2015-09-01
TWI782325B (zh) 2022-11-01
SI2624865T1 (sl) 2018-10-30
TWI679988B (zh) 2019-12-21
TW201924718A (zh) 2019-07-01
AR083338A1 (es) 2013-02-21
LT2624865T (lt) 2018-10-25
UA111731C2 (uk) 2016-06-10
TWI568445B (zh) 2017-02-01

Similar Documents

Publication Publication Date Title
US11926670B2 (en) Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
JP6456470B2 (ja) 抗pcsk9抗体を含む安定化製剤
DK2624865T3 (en) Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
EA042167B1 (ru) Стабилизированные композиции, содержащие антитела к рецептору интерлейкина-4 (il-4r)